Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory

被引:184
|
作者
Neblett, Randy [1 ]
Hartzell, Meredith M. [1 ]
Mayer, Tom G. [2 ]
Cohen, Howard [3 ]
Gatchel, Robert J. [4 ]
机构
[1] PRIDE Res Fdn, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, 5701 Maple Ave 100, Dallas, TX 75235 USA
[3] Univ Texas Arlington, Grad Sch Nursing, Arlington, TX 76019 USA
[4] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA
关键词
central sensitization inventory; central sensitization; central sensitivity syndrome; chronic pain; CENTRAL SENSITIVITY SYNDROMES; OCCUPATIONAL MUSCULOSKELETAL DISORDERS; PAIN DISABILITY QUESTIONNAIRE; IRRITABLE-BOWEL-SYNDROME; PSYCHIATRIC-DISORDERS; FIBROMYALGIA SYNDROME; RISK-FACTORS; DEPRESSION; PREVALENCE; CLASSIFICATION;
D O I
10.1111/papr.12440
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
ObjectivesThe aim of this study was to create and validate severity levels for the central sensitization inventory (CSI), a valid and reliable patient-reported outcome instrument designed to identify patients whose presenting symptoms may be related to a central sensitivity syndrome (CSS; eg, fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome), with a proposed common etiology of central sensitization (CS). MethodsBased on CSI score means and standard deviations from previously published subject samples, the following CSI severity levels were established: subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 59; and extreme = 60 to 100. The concurrent validity of the CSI severity levels was then confirmed in a separate chronic pain patient sample (58% with a CSS diagnosis and 42% without) by demonstrating associations between CSI scores and (1) the number of physician-diagnosed CSSs; (2) CSI score distributions in both CSS and non-CSS patient samples; (3) patient-reported history of CSSs; and (4) patient-reported psychosocial measures, which are known to be associated with CSSs. ResultsCompared to the non-CSS patient subsample, the score distribution of the CSS patient subsample was skewed toward the higher severity ranges. CSI mean scores moved into higher severity levels as the number of individual CSS diagnoses increased. Patients who scored in the extreme CSI severity level were more likely to report previous diagnoses of fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, tension/migraine headaches, and anxiety or panic attacks (P < 0.01). CSI severity levels were also associated with patient-reported depressive symptoms, perceived disability, sleep disturbance, and pain intensity (P 0.02). ConclusionThis study provides support for these CSI severity levels as a guideline for healthcare providers and researchers in interpreting CSI scores and evaluating treatment responsiveness.
引用
收藏
页码:166 / 175
页数:10
相关论文
共 50 条
  • [41] ESTABLISHING A CLINICALLY RELEVANT MOUSE MODEL TO STUDY NECROSIS AS A PRIMARY VARIABLE IN GLIOBLASTOMA
    Li, Jiabo
    Shih, Ling-kai
    Markwell, Steven
    Olson, Cheryl
    Sullivan, David
    Lam, Nicholas
    Brat, Daniel
    NEURO-ONCOLOGY, 2024, 26
  • [42] Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae
    Smits, Theo H. M.
    Arend, Lavinia N. V. S.
    Cardew, Sofia
    Tang-Hallback, Erika
    Mira, Marcelo T.
    Moore, Edward R. B.
    Sampaio, Jorge L. M.
    Rezzonico, Fabio
    Pillonetto, Marcelo
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (04) : 547 - 558
  • [43] Pelvic floor nerve conduction studies: Establishing clinically relevant normative data
    Olsen, AL
    Ross, M
    Stansfield, RB
    Kreiter, C
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) : 1114 - 1119
  • [44] Phenotyping Sexual Pain in Endometriosis Using the Central Sensitization Inventory
    Orr, Natasha L.
    Wahl, Kate J.
    Noga, Heather
    Allaire, Catherine
    Williams, Christina
    Bedaiwy, Mohamed A.
    Albert, Arianne
    Smith, Kelly B.
    Yong, Paul J.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (04): : 761 - 770
  • [45] SENSITIZATION CHANGES ARE COMMON AND CLINICALLY RELEVANT IN WAITLISTED KIDNEY TRANSPLANT PATIENTS.
    Lan, James H.
    Hickey, Michelle
    Zhang, Xiaohai
    Reed, Elaine F.
    Zhang, Qiuheng
    HUMAN IMMUNOLOGY, 2014, 75 : 61 - 61
  • [46] Sensitization to Quercus ilex Pollen Is Clinically Relevant in Patients With Seasonal Pollen Allergy
    Lluch-Bernal, M.
    Pedrosa, M.
    Dominguez-Ortega, J.
    Colque-Bayona, M.
    Correa-Borit, J.
    Phillips-Angles, E.
    Gomez-Traseira, C.
    Quirce, S.
    Rodriguez-Perez, R.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (05) : 338 - 340
  • [47] The Central Sensitization Inventory (CSI): some background and current trends
    Neblett, Randy
    Mayer, Tom G.
    SPINE JOURNAL, 2017, 17 (11): : 1766 - 1767
  • [48] Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory
    Knezevic, Aleksandar
    Neblett, Randy
    Colovic, Petar
    Jeremic-Knezevic, Milica
    Bugarski-Ignjatovic, Vojislava
    Klasnja, Aleksandar
    Pantelinac, Slobodan
    Pjevic, Mirjana
    PAIN PRACTICE, 2020, 20 (07) : 724 - 736
  • [49] Dimensionality and Reliability of the Central Sensitization Inventory in a Pooled Multicountry Sample
    Cuesta-Vargas, Antonio I.
    Neblett, Randy
    Chiarotto, Alessandro
    Kregel, Jeroen
    Nijs, Jo
    van Wilgen, C. Paul
    Pitance, Laurent
    Knezevic, Aleksandar
    Gatchel, Robert J.
    Mayer, Tom G.
    Viti, Carlotta
    Roldan-Jimenez, Cristina
    Testa, Marco
    Caumo, Wolnei
    Jeremic-Knezevic, Milica
    Luciano, Juan V.
    JOURNAL OF PAIN, 2018, 19 (03): : 317 - 329
  • [50] Preliminary research on the relationship between cranial autonomic symptoms and central sensitization in migraine patients using the central sensitization inventory
    Danno, Daisuke
    Wolf, Johanna
    Ishizaki, Kumiko
    Miyahara, Junichi
    Kikui, Shoji
    Yoshikawa, Hiroo
    Hirata, Koichi
    Takeshima, Takao
    CEPHALALGIA, 2019, 39 : 167 - 167